Global IV Catheters, Needles, and Syringes Market Size By Type (Syringes, Needles), By Application (Hospitals and Clinics, Diagnostic Laboratories), By Region, And Segment Forecasts, 2023 to 2032

The Global IV Catheters, Needles, and Syringes Market was valued at USD 17.4 billion in 2023 and is projected to reach USD 30.1 billion by 2031, growing at a CAGR of 7.1% during the forecast period from 2023 to 2031. This market is driven by the rising prevalence of chronic diseases, increasing hospital admissions, expanding use of injectable drugs, and the growing demand for safe, efficient, and minimally invasive drug delivery systems. The market includes essential devices widely utilized in clinical settings for administering medications, fluids, and nutrients, playing a pivotal role in modern healthcare infrastructure.

Drivers:

1. Rising Chronic Disease Prevalence:

A growing global burden of conditions like diabetes, cancer, and cardiovascular diseases has led to increased demand for intravenous and subcutaneous administration, thus boosting the use of IV catheters, needles, and syringes.

2. Increasing Surgical Procedures:

With the rising number of surgical interventions globally, particularly in aging populations, the demand for reliable intravenous access and sterile needle-based drug delivery continues to grow.

3. Advancements in Needle Safety and Product Design:

Innovations such as retractable needles, needle-free injectors, and safety-engineered syringes are improving patient safety and reducing the risk of needlestick injuries, driving adoption across healthcare settings.

Restraints:

1. Risk of Needlestick Injuries and Infections:

Despite technological improvements, improper handling or reuse of needles and syringes in under-resourced healthcare systems poses infection risks and safety challenges.

2. Regulatory Compliance and Disposal Concerns:

Stringent regulations concerning device sterility, biohazard waste management, and proper disposal add compliance burdens for manufacturers and healthcare providers.

Opportunity:

1. Growing Demand in Emerging Economies:

Rising healthcare expenditure, expanding medical infrastructure, and increasing disease awareness in countries like India, Brazil, and China offer significant growth potential for manufacturers.

2. Development of Prefilled and Auto-Disable Syringes:

As global immunization programs gain momentum and safety concerns escalate, the market is witnessing a shift toward prefilled and auto-disable syringes, especially in infectious disease control.

Market by System Type Insights:

The Syringes segment held the largest share of the market in 2023, driven by its wide applicability in drug administration, immunization, and diagnostics. Auto-disable and safety syringes are gaining prominence due to their role in preventing contamination and ensuring single-use compliance. Meanwhile, IV catheters are witnessing strong growth, particularly with the rising incidence of long-term treatments and hospitalizations requiring continuous intravenous therapy.

Market by End-Use Insights:

Hospitals accounted for the highest revenue share in 2023, representing over 45% of the global market. This dominance is attributed to the high volume of inpatient treatments, surgeries, and emergency procedures. The ambulatory surgical centers (ASCs) and home healthcare segments are expected to show accelerated growth, supported by decentralization of care, rising preference for outpatient treatment, and the availability of user-friendly injectable devices.

Market by Regional Insights:

North America led the market in 2023, owing to advanced healthcare infrastructure, high rates of chronic diseases, and the strong presence of global medical device manufacturers. However, Asia-Pacific is forecast to experience the fastest growth during the forecast period, driven by increasing healthcare access, rising health awareness, and large-scale immunization programs in countries like India, China, and Indonesia.

Competitive Scenario:

Prominent players in the Global IV Catheters, Needles, and Syringes Market include Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Smiths Medical, Nipro Corporation, ICU Medical, Inc., Cardinal Health, Medline Industries, Ltd., Gerresheimer AG, and Hindustan Syringes & Medical Devices Ltd. These companies are focusing on product innovation, strategic partnerships, and regional expansion to strengthen their global presence. Recent developments include:

2023: Becton, Dickinson launched a new generation of safety-engineered syringes tailored for mass immunization programs in low-income countries.

2024: Terumo Corporation unveiled a next-gen IV catheter line with enhanced patient comfort and antimicrobial protection.

2025: Cardinal Health partnered with a government agency to distribute auto-disable syringes for nationwide vaccine rollouts.

Scope of Work – Global IV Catheters, Needles, and Syringes Market

Report Metric Details

Market Size (2023) USD 17.4 Billion

Projected Market Size (2031) USD 30.1 Billion

CAGR (2023-2031) 7.1%

Market Segments By System Type (IV Catheters, Needles, Syringes), By End-Use (Hospitals, Clinics, ASCs, Home Healthcare), By Region

Growth Drivers Rising chronic diseases, technological innovation, increased surgical procedures

Opportunities Expansion in emerging economies, demand for prefilled/auto-disable syringes

Key Market Developments:

February 2023: BD received FDA clearance for its dual-chamber syringe platform to support combination therapies in oncology.

July 2024: Smiths Medical announced its partnership wit